A prospective randomized, double-blind study to evaluate the safety, biodistribution, and dosimetry of 68Ga-NODAGA-LM3 and 68Ga-DOTALM3 in patients with well-differentiated neuroendocrine tumors-MedSci.cn

A prospective randomized, double-blind study to evaluate the safety, biodistribution, and dosimetry of 68Ga-NODAGA-LM3 and 68Ga-DOTALM3 in patients with well-differentiated neuroendocrine tumors

Zhu, W; Cheng, Y; Jia, R; Zhao, H; Bai, C; Xu, J; Yao, S; Huo, L

JOURNAL OF NEUROENDOCRINOLOGY, 2021; 33 (): 203

科室
- - 订阅+
  - 更多科室
工具
服务